0.1096
Pomdoctor Ltd Adr stock is traded at $0.1096, with a volume of 712.65K.
It is down -5.46% in the last 24 hours and down -70.53% over the past month.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.
See More
Previous Close:
$0.1172
Open:
$0.1391
24h Volume:
712.65K
Relative Volume:
0.11
Market Cap:
$13.11M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+47.73%
1M Performance:
-70.53%
6M Performance:
-97.09%
1Y Performance:
+0.00%
Pomdoctor Ltd Adr Stock (POM) Company Profile
Name
Pomdoctor Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare POM vs HITI, PETS, SCNX, WGRX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
POM
Pomdoctor Ltd Adr
|
0.11 | 15.27M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.37 | 211.83M | 452.61M | -35.30M | 13.25M | -0.3863 |
|
PETS
Petmed Express Inc
|
2.25 | 48.37M | 182.67M | -64.87M | -22.92M | -3.1193 |
|
SCNX
Scienture Holdings Inc
|
0.4207 | 16.62M | 653.40K | -20.19M | -11.11M | -1.8091 |
|
WGRX
Wellgistics Health Inc
|
0.087 | 12.29M | 23.34M | -101.27M | -11.74M | -1.2919 |
Pomdoctor Ltd Adr Stock (POM) Latest News
Pomdoctor Posts Strong 2025 Revenue Growth but Wider Loss as IPO and R&D Spending Climb - TipRanks
POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results - ChartMill
Small Chinese Firms Withdraw Wall Street IPO Applications - Benzinga
Dow Edges Higher; Mosaic Shares Fall After Q1 Results - Benzinga
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.02% - Investing.com UK
POM Stock Price, Quote & Chart | POMDOCTOR LTDADR (NASDAQ:POM) - ChartMill
PomDoctor Limited Delays Annual 20-F Filing - TipRanks
Get insights into the top gainers and losers of Tuesday's after-hours session. - ChartMill
Here are the top movers in Tuesday's session. - ChartMill
POMPomdoctor Ltd ADR Stock Price and Quote - Finviz
Which stocks are experiencing notable movement on Tuesday? - ChartMill
Top movers in Tuesday's pre-market session - ChartMill
BC-Most Active Stocks (Associated Press) - Finviz
PomDoctor Limited Replaces Marcum Asia With HYYH CPA as Auditor - TipRanks
POM Deadline: POM Investors with Losses in Excess of $100K Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit - Barchart.com
POM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - Sahm
POM CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds PomDoctor Investors of Securities Class Action Deadline on April 13, 2026 - ChartMill
POM DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important April 13 Deadline in Securities Class Action - GlobeNewswire Inc.
PomDoctor Limited Announces Vice President Resignation Effective April 1, 2026 - The Globe and Mail
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines – POM - ChartMill
POM Deadline: Rosen Law Firm Urges PomDoctor Ltd. (NASDAQ: POM) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
POM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Pomdoctor Investors of Securities Class Action Deadline on April 13, 2026 - Sahm
Top GainersStock ScreenerSnapshot - Finviz
POM IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages PomDoctor Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action - GlobeNewswire Inc.
POM DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Pomdoctor Investors of Securities Class Action Deadline on April 13, 2026 - ChartMill
POMDOCTOR DEADLINE: ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
PomDoctor Deadline: POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit - barchart.com
POM Investor AlertPOMDoctor, Ltd. Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit - ChartMill
POM DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - Sahm
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit - Sahm
ROSEN, A TOP RANKED LAW FIRM, Encourages PomDoctor Ltd. Investors With Losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - ChartMill
Shareholders who lost money in American Depositary Receipts - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
US tries 'Monkey Scaring' To Rid Wall Street Of Suspicious Chinese Listings - Sahm
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming DeadlinesPOM - ChartMill
Pomdoctor Ltd Adr Stock (POM) Financials Data
There is no financial data for Pomdoctor Ltd Adr (POM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):